首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert opinion on therapeutic targets

缩写:EXPERT OPIN THER TAR

ISSN:1472-8222

e-ISSN:1744-7631

IF/分区:5.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2510条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Danni Li,Xinning Liu,Jinhui Lü et al. Danni Li et al.
Background: Breast cancer is a leading cause of cancer-related death among women worldwide. Aquaporin 7 (AQP7), a transmembrane protein facilitating the transport of glycerol and/or water across plasma membranes, has been...
Yuxin Liang,Lina Wang,Ziyan Yang et al. Yuxin Liang et al.
Introduction: Oxidative phosphorylation (OXPHOS) is essential for the progression of tumors and their resistance to therapy. Conventional inhibitors of OXPHOS that directly targeting the electron transport chain (ETC) act...
RuiXue Gu,Ge Li,LongHao Wang et al. RuiXue Gu et al.
Background: Tumor stemness is a key driver of therapeutic resistance and malignant progression in lung adenocarcinoma (LUAD), but its molecular basis and clinical significance remain unclear. This study explores the tumor...
Emma Melotti,Thomas Delerue,Ivo Gomperts Boneca Emma Melotti
Introduction: Despite the fact that the progress in developing new antibiotics with novel mechanism of action is limited owing to the considerable challenges involved and the modest financial returns, we are urgently need...
Prarthana Gopinath,Srikanth Swamy Swaroop B,Ganesh Venkatraman et al. Prarthana Gopinath et al.
p21-activated kinase 1 (PAK1) is a critical serine/threonine kinase involved in regulating key cellular processes driving cancer progression. While PAK1 is well-known for its contributions to the hallmarks of cancer - such as sustained prol...
Michael Maes,Abbas F Almulla,Drozdstoj Stoyanov et al. Michael Maes et al.
Introduction: Major depressive disorder (MDD) is a neuro-immune-metabolic-oxidative stress (NIMETOX) disorder. A significant proportion (50%) of individuals with MDD experience recurrence of episodes and suicidal behavior...